A radical proposal: Integrate clinical investigation into the U.S. Health Care System

Science Translational Medicine

Volumn 1, Issue 4, 2009, Pages

  Rudick, Richard A ^a,b   Cosgrove, Delos M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HEALTH CARE DELIVERY; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; ORGANIZATION AND MANAGEMENT; UNITED STATES;

BIOMEDICAL RESEARCH; DELIVERY OF HEALTH CARE; NATIONAL INSTITUTES OF HEALTH (U.S.); UNITED STATES;

EID: 77954677643     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3000296     Document Type: Note

References (17)

1. J. B. Wyngaarden, The clinical investigator as an endangered species. N. Engl. J. Med. 301, 1254-1259 (1979).
2. www.ctsaweb.org
3. AAMC Task Force II on Clinical Research, Promoting Translational and Clinical Science: The Critical Role of Medical Schools and Teaching Hospitals (Association of American Medical Colleges, Washington, DC, 2006).
4. H. B. Dickler, D. Korn, S. G. Gabbe, Promoting translational and clinical science: the critical role of medical schools and teaching hospitals. PLoS Med. 3, e378 (2006).
5. H. B. Dickler, D. Fang, S. J. Heinig, E. Johnson, D. Korn, New physician-investigators receiving National Institutes of Health research project grants: A historical perspective on the "endangered species." JAMA 297, 2496-2501 (2007).
6. T. J. Ley, L. E. Rosenberg, The physician-scientist career pipeline in 2005: Build it, and they will come. JAMA 294, 1343-1351 (2005).
7. http://grants.nih.gov/training/K30.htm
8. http://nihroadmap.nih.gov
9. http://nihroadmap.nih.gov/clinicalresearchtheme/
10. R. D. Kush, What the patient should order. Sci. Transl. Med. 1, 3cm3 (2009).
11. D. M. Cutler, The Value of Medical Care: An Economic Approach (http://www.phsi.harvard.edu/pdfs/cutler.pdf; accessed 23 August 2009).
12. AAMC Task Force I on Clinical Research, For the Health of the Public: Ensuring the Future of Clinical Research, Vol. I (Association of American Medical Colleges, Washington, DC, 1999).
13. H. Hörig, E. Marincola, F. M. Marincola, Obstacles and opportunities in translational research. Nat. Med. 11, 705-708 (2005).
14. W. F. Crowley Jr., L. Sherwood, P. Salber, D. Scheinberg, H. Slavkin, H. Tilson, E. A. Reece, V. Catanese, S. B. Johnson, A. Dobs, M. Genel, A. Korn, N. Reame, R. Bonow, J. Grebb, D. Rimoin, Clinical research in the United States at a crossroads: Proposal for a novel public-private partnership to establish a national clinical research enterprise. JAMA 291, 1120-1126 (2004).
15. H. Murillo, E. A. Reece, R. Snyderman, N. S. Sung, Meeting the challenges facing clinical research: Solutions proposed by leaders of medical specialty and clinical research societies. Acad. Med. 81, 107-112 (2006).
16. B. H. Littman, L. Di Mario, M. Plebani, F. M. Marincola, What's next in translational medicine? Clin. Sci. (London) 112, 217-227 (2007).
17. T. G. Krontiris, D. Rubenson, Matchmaking, metrics and money: A pathway to progress in translational research. Bioessays 30, 1025-1029 (2008).